Nucleix is a global leader in creating cancer diagnostic panels based on epigenetic biomarkers. Backed by OrbiMed and other leading investors, Nucleix provides a strong pipeline of products for various cancer types.
BillionToOne
8 followers
Krystal Biotech
8 followers
Dyne Therapeutics
6 followers
Sage Bionetworks
5 followers
Infinite Roots®
5 followers
Arcutis Biotherapeutics
3 followers
Biosynth
3 followers
ADMA Biologics
3 followers
Cabaletta Bio
3 followers
Argonaut Manufacturing Services
3 followers
RayzeBio
2 followers
Solid Biosciences
2 followers